WallStSmart
REVB

Revelation Biosciences Inc

NASDAQ: REVB · HEALTHCARE · BIOTECHNOLOGY

$1.12
-0.88% today

Updated 2026-05-01

Market cap
$4.32M
P/E ratio
P/S ratio
2.88x
EPS (TTM)
$-23.95
Dividend yield
52W range
$1 – $40
Volume
0.1M

Revelation Biosciences Inc (REVB) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+57.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+66.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-6.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-9.2%
2025-11-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-27$-1.65+54.9%$1.33$1.29-3.0%
2025-11-06$-1.77+81.6%$1.08$0.98-9.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-3.66$-1.65+54.9%
2025-09-30$-9.60$-1.77+81.6%
2025-06-30$-9.00$-7.01+22.1%
2025-03-31$-6.88$-2.11+69.3%
2024-12-31$-10.32$-4.98+51.7%$26964.00-28.2%
2024-09-30$-2.84$-0.84+70.4%
2024-06-30$-1.80$-5.13-185.0%
2024-03-31$-5.38$-2.46+54.3%
2023-12-31$-13.77$-8.33+39.5%$37574.00
2023-09-30$-0.30$-0.42-40.0%
2023-06-30$-0.40$-0.25+37.5%
2023-03-31$-0.65$2.79+529.2%

Frequently asked questions

Has Revelation Biosciences Inc beaten earnings estimates?
Revelation Biosciences Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +57.0% over the last 4 quarters.
How does REVB stock react to earnings?
REVB stock has moved an average of -6.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.